Dentsply Sirona (BSP:XRAY34) Cash And Cash Equivalents : R$1,637 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Dentsply Sirona Cash And Cash Equivalents?

Dentsply Sirona's quarterly cash and cash equivalents increased from Jun. 2023 (R$1,431.84 Mil) to Sep. 2023 (R$1,526.06 Mil) and increased from Sep. 2023 (R$1,526.06 Mil) to Dec. 2023 (R$1,636.53 Mil).

Dentsply Sirona's annual cash and cash equivalents declined from Dec. 2021 (R$1,917.01 Mil) to Dec. 2022 (R$1,914.57 Mil) and declined from Dec. 2022 (R$1,914.57 Mil) to Dec. 2023 (R$1,636.53 Mil).

Dentsply Sirona Cash And Cash Equivalents Historical Data

The historical data trend for Dentsply Sirona's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dentsply Sirona Cash And Cash Equivalents Chart

Dentsply Sirona Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

1,662.32

2,253.38

1,917.01

1,914.57

1,636.53

Dentsply Sirona Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial															1,914.57	1,656.34	1,431.84	1,526.06	1,636.53

Dentsply Sirona Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Dentsply Sirona (BSP:XRAY34) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Dentsply Sirona Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Dentsply Sirona's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Dentsply Sirona (BSP:XRAY34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Dentsply Sirona Inc (BSP:XRAY34) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

XRAY:USA DY2:Germany

Address

13320 Ballantyne Corporate Place, Charlotte, NC, USA, 28277-3607

Website

https://www.dentsplysirona.com

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as Byte clear aligner).

Dentsply Sirona (BSP:XRAY34) Headlines

No Headlines